Skip to main content

Table 3 Expression of FABP7 and EGFR mRNA in GBM from two independent published DNA microarray datasets

From: Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma

Dataset 1 (ref. 29) Dataset 2(ref. 30)
Case # FABP7 EGFR Case # FABP7 EGFR
47.0 227.5 763.5 1375 28.8 233.8
210.4 337.0 1113.8 276 1010.0 775.2
193.0 555.6 831.6 519 72.1 46.7
21.7 974.6 471.4 368 418.2 14.7
97.3 1277.9 146.0 157 6.3 35.2
147.9 1384.4 188.3 1162 378.0 139.9
365.0 1758.1 625.4 1644 9.8 165.8
131.7 1908.4 367.4 406 950.8 341.8
459.4 2126.0 1522.5 308 611.3 473.7
33.9 2246.2 2588.0 177 817.8 630.8
58.7 2250.7 558.9 103 313.2 74.4
158.0 2289.3 327.5 992 1024.3 842.2
22.3 2351.9 224.2 41 952.3 56.6
97.9 2480.0 578.6 1354 101.3 182.9
14.0 2662.4 1134.1 308 424.0 169.2
205.9 2746.3 357.6 408 279.7 97.3
232.0 3071.7 220.9 242 1137.2 673.9
226.6 3190.2 547.5 323 218.8 208.4
29.4 3944.2 196.8 213 219.6 49.0
68.0 4158.9 3010.9 97 352.8 87.4
5.3 4496.3 625.6 281 978.6 357.0
31.1 4831.9 7883.7 501 1166.7 64.5
83.0 5120.5 1440.0 670 461.1 444.7
80.0 5508.2 2871.1 729 1711.5 8.9
82.0 5854.7 741.7 21 1690.3 2057.1
103.6 6008.9 9373.4 630 353.7 274.0
2.6 6850.0 3259.5 263 460.3 375.6
41.3 7593.1 441.2 219 486.4 179.7
60.9 7966.5 7258.6    
46.1 8795.5 284.8    
40.3 8946.3 410.0    
58.3 11070.1 3518.5    
50.4 11956.1 10788.3    
16.3 13108.3 6798.5